BCL9 anticorps (AA 1009-1328)
Aperçu rapide pour BCL9 anticorps (AA 1009-1328) (ABIN602801)
Antigène
Voir toutes BCL9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1009-1328
-
Specificité
- Recognizes human Bcl-9 at ~149kD.
-
Purification
- Protein G purified
-
Stérilité
- Sterile filtered
-
Immunogène
-
Recombinant human Bcl-9, aa1009-1328, O00512 (E. coli).
Type of Immunogen: Recombinant protein -
Isotype
- IgG2b
-
-
-
-
Indications d'application
-
Approved: WB (0.5 μg/mL)
Usage: Suitable for use in Western blot: 0.5 μg/mL. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- 40-50 % glycerol, PBS.
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from 0.2 um sterile-filtered solution in PBS, 5 % trehalose
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Lyophilized powder may be stored at 4°C for short-term only. Reconstituted product is stable for 1 year at -20°C.
-
-
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
-
Autre désignation
- BCL9
-
Sujet
-
Name/Gene ID: BCL9
Family: Cancer
Synonyms: BCL9, Bcl-9, B-cell CLL/lymphoma 9, B-cell CLL/lymphoma 9 protein, LGS, Protein legless homolog, B-cell lymphoma 9 protein -
ID gène
- 607
-
Pathways
- Stem Cell Maintenance
Antigène
-